These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17448572)

  • 1. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients.
    Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
    Neurobiol Aging; 2008 Oct; 29(10):1474-84. PubMed ID: 17448572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
    Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
    Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects.
    Sala SG; Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
    J Pharmacol Exp Ther; 2008 Jan; 324(1):352-9. PubMed ID: 17928568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced proliferation of lymphoblasts from patients with Alzheimer dementia associated with calmodulin-dependent activation of the na+/H+ exchanger.
    Urcelay E; Ibarreta D; Parrilla R; Ayuso MS; Martín-Requero A
    Neurobiol Dis; 2001 Apr; 8(2):289-98. PubMed ID: 11300724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
    Levitt RJ; Zhao Y; Blouin MJ; Pollak M
    Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts.
    Cavazzin C; Bonvicini C; Nocera A; Racchi M; Kasahara J; Tardito D; Gennarelli M; Govoni S; Racagni G; Popoli M
    Neurobiol Aging; 2004 Oct; 25(9):1187-96. PubMed ID: 15312964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
    Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+/calmodulin-dependent modulation of cell cycle elements pRb and p27kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia.
    de las Cuevas N; Urcelay E; Hermida OG; Saíz-Diaz RA; Bermejo F; Ayuso MS; Martín-Requero A
    Neurobiol Dis; 2003 Aug; 13(3):254-63. PubMed ID: 12901840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia.
    Auld CA; Morrison RF
    Obesity (Silver Spring); 2006 Dec; 14(12):2136-44. PubMed ID: 17189539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.
    Zancai P; Dal Col J; Piccinin S; Guidoboni M; Cariati R; Rizzo S; Boiocchi M; Maestro R; Dolcetti R
    Oncogene; 2005 Apr; 24(15):2483-94. PubMed ID: 15735731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.
    Kudo Y; Kitajima S; Ogawa I; Miyauchi M; Takata T
    Oral Oncol; 2005 Feb; 41(2):105-16. PubMed ID: 15695111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients.
    Muñoz U; Bartolomé F; Esteras N; Bermejo-Pareja F; Martín-Requero A
    Cell Mol Life Sci; 2008 Nov; 65(21):3507-19. PubMed ID: 18818877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis.
    Hoozemans JJ; Stieler J; van Haastert ES; Veerhuis R; Rozemuller AJ; Baas F; Eikelenboom P; Arendt T; Scheper W
    Exp Gerontol; 2006 Apr; 41(4):380-6. PubMed ID: 16564150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons.
    Akashiba H; Matsuki N; Nishiyama N
    J Neurochem; 2006 Nov; 99(3):733-44. PubMed ID: 16824045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity.
    Yang HY; Yang H; Zhao R; Lee MH
    J Cell Biochem; 2006 May; 98(1):128-38. PubMed ID: 16365885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes.
    Wilson KC; Cattel DJ; Wan Z; Rahangdale S; Ren F; Kornfeld H; Sullivan BA; Cruikshank WW; Center DM
    Cell Immunol; 2005 Sep; 237(1):17-27. PubMed ID: 16289056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
    Li L; Iwamoto Y; Berezovskaya A; Boussiotis VA
    Nat Immunol; 2006 Nov; 7(11):1157-65. PubMed ID: 17013388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial inhibition of the proteasome enhances the activity of the myelin basic protein promoter.
    Calatayud CA; García CI; Paez PM; Pasquini JM; Soto EF; Pasquini LA
    Dev Neurosci; 2009; 31(3):169-80. PubMed ID: 19145069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.